Test bank for claytons basic pharmacology for nurses 18th edition by willihnganz isbn-isbn-all-chapters-a-guide.

Test Bank
|

, Chapter 1: Drug Definitions, Standards, and Information Sources Test Bank
| | | | | | | | |




MULTIPLE |CHOICE

1. What |is |the |name |under |which |a |drug |is |listed |by |the |U.S. |Food |and |Drug |Administration
|(FDA)?

a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: | C
The |official |name |is |the |name |under |which |a |drug |is |listed |by |the |FDA. |The |brand |name, |or
|trademark, |is |the |name |given |to |a |drug |by |its |manufacturer. |The |nonproprietary, |or |generic,

|name |is |provided |by |the |U.S. |Adopted |Names |Council.




DIF: |Cognitive |Level: |Knowledge |REF: |p. |1 |OBJ: |2TOP: | Nursing
|Process |Step: |Assessment

MSC: | NCLEX |Client |Needs |Category: |Safe, |Effective |Care |Environment

2. Which |source |contains |information |specific |to |nutritional |supplements?
a. USP |Dictionary |of |USAN |&|International |Drug |Names
b. Natural |Medicines |Comprehensive |Database
c. United |States |Pharmacopoeia/National |Formulary |(USP |NF)
d. Drug |Interaction |Facts
ANS: | C
United |States |Pharmacopoeia/National |Formulary |contains |information |specific |to |nutritional
|supplements. |USP |Dictionary |of |USAN | & |International |Drug |Names |is |a |compilation |of |drug

|names, |pronunciation |guide, |and |possible |future |FDA |approved |drugs; |it |does |not |include

|nutritional |supplements. |Natural |Medicines |Comprehensive |Database |contains |evidence |based

|information |on |herbal |medicines |and |herbal |combination |products; |it |does |not |include

|information |specific |to |nutritional |supplements. |Drug |Interaction |Facts |contains

|comprehensive |information |on |drug |interaction |facts; |it |does |not |include |nutritional

|supplements.




DIF: |Cognitive |Level: |Knowledge |REF: |p. |2 |OBJ: |4TOP: | Nursing
|Process |Step: |Assessment

MSC: | NCLEX |Client |Needs |Category: |Physiological |Integrity

3. What |is |the |most |comprehensive |reference |available |to |research |a |drug |interaction?
a. Drug |Facts |and |Comparisons
b. Drug |Interaction |Facts
c. Handbook |on |Injectable |Drugs
d. Martindale—The |Complete |Drug |Reference
ANS: | B
First |published |in |1983, |Drug |Interaction |Facts |is |the |most |comprehensive |book |available
|ondrug |interactions. |In |addition |to |monographs |listing |various |aspects |of |drug |interactions, |this

|information |is |reviewed |and |updated |by |an |internationally |renowned |group |of |physicians

|andpharmacists |with |clinical |and |scientific |expertise.

,DIF: |Cognitive |Level: |Comprehension |REF: |p. |3 |OBJ: |3TOP:

, Nursing |Process |Step: |Assessment
MSC: | NCLEX |Client |Needs |Category: |Physiological |Integrity

4. The |physician |has |written |an |order |for |a |drug |with |which |the |nurse |is |unfamiliar. |Which |section
|of |the |Physicians’ |Desk |Reference |(PDR) |is |most |helpful |to |get |information |about |this |drug?

a. Manufacturer’s |section
b. Brand |and |Generic |Name |section
c. Product |Category |section
d. Product |Information |section
ANS: |B
|




DIF: |Cognitive |Level: |Comprehension |REF: |p. |3 |OBJ: |4TOP:
Nursing |Process |Step: |Planning
MSC: | NCLEX |Client |Needs |Category: |Physiological |Integrity

5. Which |online |drug |reference |makes |available |to |health |care |providers |and |the |public |a
|standard, |comprehensive, |up |to |date |look |up |and |downloadable |resource |about |medicines?

a. American |Drug |Index
b. American |Hospital |Formulary
c. DailyMed
d. Physicians’ |Desk |Reference |(PDR)
ANS: | C
DailyMed |makes |available |to |health |care |providers |and |the |public |a |standard, |comprehensive, |up
|to |date |look |up |and |downloadable |resource |about |medicines. |The |American |Drug |Index |is |not

|appropriate |for |patient |use. |The |American |Hospital |Formulary |is |not |appropriate |for |patient

|use. |The |PDR |is |not |appropriate |for |patient |use.




DIF: |Cognitive |Level: |Knowledge |REF: |p. |4 |OBJ: |5TOP: | Nursing
|Process |Step: |Implementation

MSC: | NCLEX |Client |Needs |Category: |Physiological |Integrity

6. Which |legislation |authorizes |the |FDA |to |determine |the |safety |of |a |drug |before |its |marketing?
a. Federal |Food, |Drug, |and |Cosmetic |Act |(1938)
b. Durham |Humphrey |Amendment |(1952)
c. Controlled |Substances |Act |(1970)
d. Kefauver |Harris |Drug |Amendment |(1962)
ANS: | A
The |Federal |Food, |Drug, |and |Cosmetic |Act |of |1938 |authorized |the |FDA |to |determine |the |safety
|of |all |drugs |before |marketing. |Later |amendments |and |acts |helped |tighten |FDA |control |and

|ensure |drug |safety. |The |Durham |Humphrey |Amendment |defines |the |kinds |of |drugs |that |cannot

|be |used |safely |without |medical |supervision |and |restricts |their |sale |to |prescription |by |a |licensed

|practitioner. |The |Controlled |Substances |Act |addresses |only |controlled |substances |and |their

|categorization. |The |Kefauver |Harris |Drug |Amendment |ensures |drug |efficacy |and |greater |drug

|safety. |Drug |manufacturers |are |required |to |prove |to |the |FDA |the |effectiveness |of |their |products

|before |marketing |them.




DIF: |Cognitive |Level: |Knowledge |REF: |p. |4 |OBJ: |8TOP: | Nursing
|Process |Step: |Assessment

MSC: | NCLEX |Client |Needs |Category: |Physiological |Integrity

7. Meperidine |(Demerol) |is |a |narcotic |with |a |high |potential |for |physical |and |psychological